SCHEMBL1855602

SCHEMBL1855602

O=C(O)[C@H](Cc1ccc(OCc2ccccc2)cc1)NCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.62
GPR34 Q9UPC5 4/20 0.61
PPARA Q07869 2/20 0.59
MME P08473 1/20 0.59
ACE P12821 1/20 0.59
CPA1 P15085 1/20 0.59
ACE2 Q9BYF1 1/20 0.59
BCHE P06276 1/20 0.56
GPR132 Q9UNW8 1/20 0.55
MMP9 P14780 1/20 0.55
MMP8 P22894 1/20 0.55
FFAR1 O14842 1/20 0.55
FFAR4 Q5NUL3 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6034470 1.00 PPARG (0.62) PPARGGPR34PPARAMMEACE
SCHEMBL8413779 1.00 PPARG (0.62) PPARGGPR34PPARAMMEACE
SCHEMBL8413776 1.00 PPARG (0.62) PPARGGPR34PPARAMMEACE
SCHEMBL6034466 1.00 PPARG (0.62) PPARGGPR34PPARAMMEACE
SCHEMBL6483477 0.88 PPARG (0.65) PPARGGPR34PPARAMMEACE
SCHEMBL3288556 0.87 MMP9 (0.69) PPARGGPR34PPARAMMEACE
SCHEMBL1069240 0.87 MMP9 (0.69) PPARGGPR34PPARAMMEACE
SCHEMBL11581853 0.85 MME (0.56) MMEMMP9
SCHEMBL73955 0.85 MME (0.56) MMEMMP9
SCHEMBL497336 0.85 MME (0.56) MMEMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4025200-A1 LIQUID COMPOSITIONS COMPRISING A LEVODOPA AMINO ACID CONJUGATE AND USES THEREOF Neuroderm Ltd (IL) 2022-07-13 EP disclosed
WO-2021044420-A1 LIQUID COMPOSITIONS COMPRISING A LEVODOPA AMINO ACID CONJUGATE AND USES THEREOF NEURODERM, LTD. (IL) 2021-03-11 WO disclosed
EP-1697400-B1 BIPHENYL-SUBSTITUTED ANTIBACTERIAL MACROCYCLES AICURIS GMBH & CO KG (DE) 2011-05-25 EP disclosed
US-4736066-A Intermediate for substituted peptide compounds E. R. SQUIBB & SONS, INC. (US) 1988-04-05 US disclosed